Table 3 Competing risks regression. Sub-distribution hazard ratios of cause-specific mortality during follow-up
Unadjusted SHR (95% CI) | p-value | Age-adjusted SHR (95% CI) | p-value | |
|---|---|---|---|---|
STEMI n = 4899 | ||||
Cardiovascular death | ||||
Women versus men | 1.76 (1.49–2.08) | <0.0001 | 1.03 (0.87–1.22) | 0.750 |
Cancer death | ||||
Women versus men | 1.20 (0.80–1.79) | 0.378 | 0.79 (0.51–1.22) | 0.286 |
Other-cause death | ||||
Women versus men | 2.21 (1.63–2.99) | <0.0001 | 1.26 (0.91–1.74) | 0.171 |
NSTEMI n = 5159 | ||||
Cardiovascular death | ||||
Women versus men | 1.63 (1.42–1.87) | <0.0001 | 0.97 (0.84–1.12) | 0.659 |
Cancer death | ||||
Women versus men | 0.97 (0.74–1.29) | 0.852 | 0.76 (0.56–1.03) | 0.072 |
Other-cause death | ||||
Women versus men | 1.52 (1.26–1.84) | <0.0001 | 0.90 (0.74–1.10) | 0.308 |